Bayer AG 'disappointed' after losing India patent fight Economic Times NEW DELHI: Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and kidney cancer. The German company's reaction came ... |
